Patents by Inventor Joseph Schoepfer

Joseph Schoepfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060211747
    Abstract: The present invention relates to methods of searching/screening for compounds which inhibit the activity of the ubiquitin conjugating enzyme Cdc34 in a zinc-mediated manner, to compounds obtainable by such a method, to a method of treating mammalian subjects with such compounds, to pharmaceutical compositions containing such compounds, to the use of such compounds for the treatment of diseases which respond to an inhibition of the activity of Cdc34 such as proliferative diseases, especially tumor diseases, and to the use of such compounds for the preparation of such pharmaceutical compositions for the treatment of such diseases.
    Type: Application
    Filed: September 14, 2005
    Publication date: September 21, 2006
    Inventors: Pascal Furet, Francesco Hofmann, Edgar Jacoby, Joseph Schoepfer
  • Publication number: 20050222171
    Abstract: The invention relates to the use of pyrazolo[1,5a]pyrimidin-7-yl amine compounds and salts thereof in the treatment of kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases, novel pyrazolo[1,5a]pyrimidin-7-yl amine compounds, and a process for the preparation of the novel pyrazolo[1,5a]pyrimidin-7-yl amine compounds.
    Type: Application
    Filed: January 20, 2005
    Publication date: October 6, 2005
    Inventors: Guido Bold, Andreas Floersheimer, Pascal Furet, Patricia Imbach, Keiichi Masuya, Joseph Schoepfer
  • Publication number: 20050171105
    Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, EGF-R, c-erbB2 kinase (HER-2), CHK2, FGFR3, p70S6K, PKC, PDGF-R, p38, TGF?, KDR, c-Kit, b-RAF, c-RAF, FLT1 and/or FLT4 kinases.
    Type: Application
    Filed: September 30, 2004
    Publication date: August 4, 2005
    Applicants: IRM LLC, Novartis AG
    Inventors: Greg Chopiuk, Pascal Furet, Nathanael Gray, Patricia Imbach, Yi Liu, Joseph Schoepfer, Ruo Steensma